TrialJAMA dermatology2026

Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label Extension.

Matthias Augustin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.